DIRECT INTEGRATION OF MULTILEVEL NETWORK META-REGRESSION POSTERIOR DISTRIBUTIONS INTO COST-EFFECTIVENESS MODELS FOR DECISION-MAKING TAILORED TO LOCAL TARGET POPULATIONS
Author(s)
Jan Tužil, MSc, PhD1, Rebecca Harvey, MSc1, Rishika Sharma, MSc, MEng2, Yael Arturo Rodriguez-Guadarrama, MSc2, Frank van Hees, PhD2, Nathaniel Smith, PhD2.
1Statistics, Maple Health Group LLC., New York, NY, USA, 2Health Economics, Maple Health Group LLC., New York, NY, USA.
1Statistics, Maple Health Group LLC., New York, NY, USA, 2Health Economics, Maple Health Group LLC., New York, NY, USA.
OBJECTIVES: Multilevel network meta-regression (ML-NMR) allows prediction of relative and absolute effects in target populations, including those external to the evidence network. These are typically collapsed into static estimates before being incorporated into cost-effectiveness models (CEMs), limiting the ability to tailor estimates to the target population relevant for decision-making. We propose a theoretical framework for embedding ML-NMR posterior samples exported in Convergence Diagnosis and Output Analysis (CODA) format directly into an Excel-based CEM, enabling dynamic predictions of efficacy and safety inputs based on local population characteristics.
METHODS: The fitted ML-NMR is summarised in exportable components: posterior draws for model parameters including covariate beta coefficients, borrowed covariance structures, and marginal covariate distributions. These populate a parameter input sheet. The user specifies the local target population via two inputs: baseline risk (comparator response) and baseline characteristics (e.g. age ± variance). In the context of probabilistic CEMs, efficacy estimates can be tailored to the target population by drawing a parameter vector directly from the CODA samples and numerically integrating the inverse-link-transformed predictions over the local population's covariate distribution. This marginalization step yields a population-average (marginal) estimate on the natural scale, respecting the non-collapsibility of non-linear links. Individual draws can be directly used for the probabilistic sensitivity analysis.
RESULTS: Conceptually, the approach preserves joint parameter uncertainty, performs the marginalisation at the point of decision-making rather than at analysis stage, avoids the information loss of point-estimate transfer, and enables one fitted model serve heterogeneous decision contexts without refitting. It reflects effect-modification, prognostic effects & baseline risk. The Excel-resident CODA samples make adjustment accessible and transparent to HTA reviewers.
CONCLUSIONS: Direct CODA-to-CEM integration reframes ML-NMR as a live input layer rather than a one-off estimate, aligning population-adjusted indirect comparisons with the practical realities of HTA modelling. The computational costs associated with CODA-to-CEM merits further evaluation.
METHODS: The fitted ML-NMR is summarised in exportable components: posterior draws for model parameters including covariate beta coefficients, borrowed covariance structures, and marginal covariate distributions. These populate a parameter input sheet. The user specifies the local target population via two inputs: baseline risk (comparator response) and baseline characteristics (e.g. age ± variance). In the context of probabilistic CEMs, efficacy estimates can be tailored to the target population by drawing a parameter vector directly from the CODA samples and numerically integrating the inverse-link-transformed predictions over the local population's covariate distribution. This marginalization step yields a population-average (marginal) estimate on the natural scale, respecting the non-collapsibility of non-linear links. Individual draws can be directly used for the probabilistic sensitivity analysis.
RESULTS: Conceptually, the approach preserves joint parameter uncertainty, performs the marginalisation at the point of decision-making rather than at analysis stage, avoids the information loss of point-estimate transfer, and enables one fitted model serve heterogeneous decision contexts without refitting. It reflects effect-modification, prognostic effects & baseline risk. The Excel-resident CODA samples make adjustment accessible and transparent to HTA reviewers.
CONCLUSIONS: Direct CODA-to-CEM integration reframes ML-NMR as a live input layer rather than a one-off estimate, aligning population-adjusted indirect comparisons with the practical realities of HTA modelling. The computational costs associated with CODA-to-CEM merits further evaluation.
Conference/Value in Health Info
2026-11, ISPOR Europe 2026, Vienna, Austria
Value in Health, Volume 29, Issue 12S
Code
MSR285
Topic
Economic Evaluation, Health Technology Assessment, Methodological & Statistical Research
Disease
No Additional Disease & Conditions/Specialized Treatment Areas